| Target Price | $48.86 |
| Price | $54.74 |
| Deviation | 10.75% |
| Number of Estimates | 11 |
| 11 Analysts have issued a price target Amrize 2026 . The average Amrize target price is $48.86. This is 10.75% lower than the current stock price. The highest price target is $52.50 4.09% , the lowest is $32.38 40.84% . | |
| A rating was issued by 16 analysts: 11 Analysts recommend Amrize to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Amrize stock has an average upside potential 2026 of 10.75% . Most analysts recommend the Amrize stock at Purchase. |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stephens & Co. |
➜
Overweight
|
Initiated | Nov 14 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Nov 03 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Nov 03 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 30 2025 |
| Citigroup |
➜
Buy
|
Initiated | Oct 17 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 14 2025 |
| Wells Fargo |
➜
Overweight
|
Initiated | Oct 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Initiated
Stephens & Co.:
➜
Overweight
|
Nov 14 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Nov 03 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Nov 03 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 30 2025 |
|
Initiated
Citigroup:
➜
Buy
|
Oct 17 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 14 2025 |
|
Initiated
Wells Fargo:
➜
Overweight
|
Oct 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


